A real-world study on prevalence of and outcomes related to brain metastases among patients with HER2-positive metastatic breast cancer (mBC)

被引：0
作者：
Collins, J. [1 ]
Varghese, D. [2 ]
Miranda, M. [3 ]
Nordstrom, B. [4 ]
Murphy, B. [5 ]
Harland, D. [6 ]
机构：
[1] Evidera Waltham, Res, Waltham, MA USA
[2] AstraZeneca, Real World Evidence Generat & Epidemiol, Gaithersburg, MD USA
[3] AstraZeneca, Stat, Cambridge, England
[4] Evidera Waltham, Epidemol, Real World Evidence, Waltham, MA USA
[5] Evidera Waltham, Stat, Waltham, MA USA
[6] AstraZeneca, Global Med Affairs, Cambridge, England
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷
关键词：
D O I：
10.1016/j.annonc.2022.03.205
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
186P
引用
收藏
页码：S213 / S213
页数：1
相关论文
共 50 条
[31]   Emerging treatment options for the management of brain metastases in patients with HER2-positive metastatic breast cancer [J].
Chien, A. Jo ;
Rugo, Hope S. .
BREAST CANCER RESEARCH AND TREATMENT, 2013, 137 (01) :1-12
[32]   Emerging treatment options for the management of brain metastases in patients with HER2-positive metastatic breast cancer [J].
A. Jo Chien ;
Hope S. Rugo .
Breast Cancer Research and Treatment, 2013, 137 :1-12
[33]   Pyrotinib in HER2-Positive local advanced or metastatic breast cancer patients: Results from a retrospective study in real-world setting [J].
Wang, Q. ;
Chen, C. ;
Wang, Y. ;
Sun, S. ;
Cheng, J. .
EUROPEAN JOURNAL OF CANCER, 2020, 138 :S58-S58
[34]   Efficacy and safety of pyrotinib-containing regimen in the patients with HER2-positive metastatic breast cancer: A multicenter real-world study [J].
Yin, Sha ;
Chi, Yajing ;
Du, Yangyang ;
Wang, Jingfen ;
Shan, Changping ;
Yi, Weiwei ;
Shang, Mao ;
Man, Xiaochu ;
Tan, Qiaorui ;
Li, Huihui .
CANCER MEDICINE, 2023, 12 (03) :2333-2344
[35]   Effectiveness and safety of pyrotinib-based therapy in patients with HER2-positive metastatic breast cancer: A real-world retrospective study [J].
Li, Chao ;
Bian, Xiaoli ;
Liu, Zhaoyun ;
Wang, Xinzhao ;
Song, Xiang ;
Zhao, Wei ;
Liu, Yansong ;
Yu, Zhiyong .
CANCER MEDICINE, 2021, 10 (23) :8352-8364
[36]   Pyrotinib Treatment in Patients With HER2-positive Metastatic Breast Cancer and Brain Metastasis: Exploratory Final Analysis of Real-World, Multicenter Data [J].
Anwar, Munawar ;
Chen, Qitong ;
Ouyang, Dengjie ;
Wang, Shouman ;
Xie, Ning ;
Ouyang, Quchang ;
Fan, Peizhi ;
Qian, Liyuan ;
Chen, Gannong ;
Zhou, Enxiang ;
Guo, Lei ;
Gu, Xiaowen ;
Ding, Boning ;
Yang, Xiaohong ;
Liu, Liping ;
Deng, Chao ;
Xiao, Zhi ;
Li, Jing ;
Wang, Yunqi ;
Zeng, Shan ;
Hu, Jinhui ;
Zhou, Wei ;
Qiu, Bo ;
Wang, Zhongming ;
Weng, Jie ;
Liu, Mingwen ;
Li, Yi ;
Tang, Tiegang ;
Wang, Jianguo ;
Zhang, Hui ;
Dai, Bin ;
Tang, Wuping ;
Wu, Tao ;
Xiao, Maoliang ;
Li, Xiantao ;
Liu, Hailong ;
Li, Lai ;
Yi, Wenjun .
CLINICAL CANCER RESEARCH, 2021, 27 (16) :4634-4641
[37]   A real-world study of treatment sequences and second-line clinical outcomes in patients with HER2-positive metastatic breast cancer in US community practice [J].
Varghese, Della ;
Cruz, Giovanna I. ;
Johanson, Colden ;
Toland, Liz ;
Miranda, Miguel ;
Faherty, Eleanor C. ;
Harland, David ;
Kaplan, Henry G. .
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2024, 29 (06) :780-789
[38]   Neratinib in HER2-Positive Breast Cancer With Brain Metastases [J].
Dekker, Tim Johannes Adrianus .
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03) :251-+
[39]   Treatment of brain metastases of HER2-positive breast cancer [J].
Heudel, P. ;
Tredan, O. ;
Cassier, P. ;
Ray-Coquard, I. ;
Guastalla, J. -P. ;
Bachelot, T. .
ONCOLOGIE, 2012, 14 (01) :41-44
[40]   Characteristics of patients with brain metastases from HER2-positive breast cancer [J].
Laakmann, E. ;
Witzel, I. ;
Neunhoeffer, T. ;
Park-Simon, T-W. ;
Weide, R. ;
Riecke, K. ;
Polasik, A. ;
Schmidt, M. ;
Puppe, J. ;
Mundhenke, C. ;
Luebbe, K. ;
Hesse, T. ;
Thill, M. ;
Zahm, D-M. ;
Denkert, C. ;
Fehm, T. ;
Nekljudova, V. ;
Rey, J. ;
Loibl, S. ;
Mueller, V. .
ANNALS OF ONCOLOGY, 2021, 32 :S63-S64
12345